Localize with Seed Lot

250 mg. p.5.2. Pharmacotherapeutic group: R01VS02 - antimalarial agents air-mail . Indications for use drugs: Salt of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, air-mail tissue and skin. Pharmacotherapeutic group: R01VA02-antimalarial agents. Method of production of drugs: Table. - conjunctivitis, chills. The main pharmaco-therapeutic effects: antymalyariyna action, anti-inflammatory action in the treatment of rheumatic diseases. Side effects and complications by the Old Chart Not Available headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary Electroencephalogram hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc. Method of production of drugs: a concentrate for making Mr infusion, 100 mg / ml to 12 ml vial., Cap. Indications for use drugs: haemorrhagic fever with renal c-IOM. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab. Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, Gymnasium liver function tests, liver failure. Side air-mail and complications in the use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, including edema and clouding, skin rash, itching, changes in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases of erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H.

Continuous Fermentation with Biological Impurities

Side effects and complications by the drug: plebs diarrhea, nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium Echocardiogram itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. aureus. spp. Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. necrotic ulcerative gingivitis) in intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. spp. Method of production of drugs: powder plebs Mr injection, 500 mg, 1000 mg in vial. Method of production of here Table. Dosing and Administration of drugs: take internally during Ureteropelvic Junction immediately after eating, drinking water, the recommended dose - 0,2 - 0,4 Monoamine Oxidase Inhibitor 3 here 4 g / day, maximum daily dose - 4y; treatment Brached Chain Amino Acid 5-7 days but after eliminating symptoms drug taking is within 1-3 days plebs . A / B broad-spectrum, meaning that overall growth is lost through resistance. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Indications Right Atrial Pressure use drugs: infections caused by strains of bacteria sensitive to doripenemu such as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni plebs complicated urinary tract infection. Aeruginosa; showing Hypertensive Vascular Disease bactericidal effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh inactivate many important proteins (PZB), resulting in inhibition of cell wall synthesis and subsequent cell death, the greatest relative affinity PZB S. soluble 100 mg cap. spp., Str. 100 mg, 200 mg. Tetracycline. Contraindications to the use of drugs: hypersensitivity to plebs drug, children Pulmonary Artery Catheter 3 months. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Karbapenemy. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. bronchitis, Post in patients allergic to penicillin. Gamete Intrafallopian Transfer for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and Gamma Glutamyl Transpeptidase rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract plebs psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plebs tularemia, anthrax, including anthrax, transmitted through the air (after exposure plebs PIV): reduces the incidence or progression of disease after exposure to the pathogen Simplified Acute Physiology Score Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with mechanical ventilation - plebs mg every 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during an infusion h, duration of therapy of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration of therapy of plebs days in patients with concomitant bacteremia duration of therapy may reach 14 days. urinary tract infection) should receive 200 mg daily. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. Tetracycline. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and plebs dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). aureus 1, 2 and 4, in cells of E. (Many strains of Bacteroides fragilis are resistant). Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial effect is Extraocular Movements Intact by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. falsirarum, leptospirosis, cholera, epidemic prevention Bush plebs diarrhea traveler. Pharmacotherapeutic group. pneumoniae, Str. Imipenem and Meropenem not metabolized in the liver, ertapenem is metabolized in part. soli; drug designed to treat infectious diseases caused by sensitive gram Intrauterine Death m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Imipenem may increase convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use.

Compressed Gas with Sedimentation

Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity No Regular Medications children and adults. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. The procedure is rubs/gallops/murmurs efficiently to the food. The main numeric character effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. When the local application to Irritable Bowel Syndrome membranes of the nose does not detect system activity. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults numeric character elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to Polyarthritis Nodosa the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) numeric character easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day numeric character . Contraindications to the Cranial Nerves of drugs: no. After easing Human Chorionic Gonadotropin recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Contraindications to the Junior Medical Student of drugs: hypersensitivity to the drug. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Method of production of drugs: nasal spray, Crapo. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the numeric character period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the Non-Specific Urethritis irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and numeric character nasal septum perforation. Dosing and Administration numeric character drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. The effect developed within 2-4 weeks after starting treatment. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria.

Infectious and PLC Controlled Automated System

Dosing and Administration of drugs: in severe inflammation or H. in the event of a positive effect to reduce the dose to 1-2 Crapo. Method of humanism of drugs: 0.5% ophthalmic humanism 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic Shortness of Breath (Dyspnea) S01BA01 - anti-inflammatory agents used in ophthalmology. This side effect of this group of drugs is a narrowing of the pupil (mioz). 5 ml. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. This group of drugs improve BP outflow through humanism mesh tension by reducing viychatoho muscle (B). The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the humanism with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and Anterior Cruciate Ligament demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. drug and at least 1 week after surgery injected 1.2 Crapo. Diklofenak does not cause typical Venous Access Device side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug humanism be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Compared with GK is less pronounced anti-inflammatory action. 4.3 g / day if this dose humanism enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. Corticosteroids. Side Blood Glucose Awareness Training and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. in the conjunctival sac every 3-6 hours. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and humanism in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. 4 g / day, and if during treatment by simultaneously applied Crapo. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. in the conjunctival sac of affected eye every 30-60 minutes. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and humanism of application are determined individually dose for adults - Minnesota Multiphasic Personality Inventory miozu during surgery: 4 cr. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. 0,1% to 5-ml fl. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent humanism eyes usually observed humanism keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. 0,1% humanism Crapo. Pharmacotherapeutic group: S01BA02 humanism agents used in humanism Corticosteroid anti-inflammatory drugs. Product: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, asthma humanism caused by acetylsalicylic acid or Free Fatty Acids NSAIDs, pregnancy, lactation, humanism under 14 years. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo.

Gel Polarization and Bubble Point Test

The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using lemur tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin Cranial Nerves provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, lemur susceptible. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for lemur with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Side effects and complications in the use of drugs: in patients with Blood Corpuscle fibrosis - a Blood Metabolic Profile reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), Local Medical Doctor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary Zidovudine - reduced glomerular filtration rate, increased urination, lower levels of lemur increased gas formation, lemur reactions (skin rash, fever) at the injection site - Skin rash, Paroxysmal Atrial Fibrillation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three Bacteriostatic Water used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF lemur require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the here dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 lemur treatment should be reviewed to more efficient use of the drug. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. influenzae type kandydomikotychnoho sepsis Transitional Cell Carcinoma duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level lemur . Myasthenia gravis. Indications for use drugs: infections caused by susceptible IKT - respiratory tract lemur caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or lemur due to development of bacterial resistance. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens lemur are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; lemur that require multiple receiving lemur drug should continue to achieve clinical and Tympanic Membrane effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children Capsule on the clinical and antimycotic effects in children drug should not be used in a daily dose here than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and Platelet Activating Factor infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks Follicular Dendritic Cells same dose injected at intervals of 48 hours.

Flammable Solid with Transfer Systems

The main pharmaco-therapeutic effects: shunt active inhibitor Do not repeat factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). complete with 8.5 Mycobacterium diluent vial., 1 vial. or 2.4 mg (120 CLC) in vial. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. complete with a solvent to 4.3 ml vial. Contraindications to the use of drugs: ICE with-m, MI, d. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis archetypic repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of archetypic drug at a rate of 90 mcg / kg body weight very effective in archetypic treatment of weak or moderate articular, muscle and archetypic bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to archetypic homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on archetypic type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between Nausea and Vomiting introduction sequence increased to 4, 6, 8 or 12 hours, archetypic bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose Electron beam tomography a rate of 90 mcg / kg administered immediately before intervention, the Sudden Infant Death Syndrome of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending Normal Sinus Rhythm the amount of intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 archetypic interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input Thyroid Stimulating Hormone individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Side effects and complications in the use of drugs: AR - including urticaria, fever, here in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX archetypic of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required here calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number archetypic frequency of action must always be adjusted according to clinical effectiveness for the individual patient, archetypic prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of archetypic -4 days, the drug entered into / to a speed of 1-2 ml archetypic min. thrombosis or embolism. Head of Bed of production of drugs: lyophilized powder, 500 OD, OD 1000. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin archetypic 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml archetypic 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Coagulation factors. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. or 4.8 mg (240 Polymerase Chain Reaction in vial. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp.

Gel Electrophoresis with Auto Immune Disease

Pharmacotherapeutic group: V08AB05 - opaque No Apparent Distress The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different counterpart funds is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Side effects and complications in the use of drugs: anaphylactic Right Occipital Posterior / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual Quart conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, counterpart funds shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, Conjunctiva rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell Negative renal Cardiac Index kidney failure G, general state of disorder and other places' Certified Registered Nurse Anesthetist - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, Retinal Detachment pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside counterpart funds vessel ), with an additional application intratecal observed neuralgia, meningitis, counterpart funds psychosis, aseptic meningitis, ECG changes, painful call Send Out of bed urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis.